X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

INFI

Closed

Infinity Pharmaceuticals Inc

0.0037
0.0000 (0.00%)
Last Update: 01 Dec 2023 17:30:00
Yesterday: 0.0037
Day's Range: 0.003 - 0.0046
Send
When Written:
 
0.1447
Infinity Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing novel medicines for the treatment of cancer. The company was founded in 2001 and is headquartered in Cambridge, Massachusetts. Infinity's lead product candidate is IPI-549, a potent and selective inhibitor of phosphoinositide-3-kinase (PI3K)-gamma. The company is also developing several other small molecule and biologic drug candidates targeting various cancer pathways. Infinity has collaborations with several pharmaceutical companies, including AbbVie, Bristol-Myers Squibb, and Verastem Oncology. The company's mission is to deliver innovative medicines that improve the lives of patients with cancer.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X